CDA and myeloid leukemia: Combined treatment with dCF and Ara A effectively induced differentiation in monocytoid leukemia cells (U937, THP-1, P39/TSU, JOSK-M). Among myeloid leukemia cells (NB4, HL-60), CdA was the most potent analog in promoting differentiation, with or without ATRA.